| Reactive Oxygen Species in Metabolic and Inflammatory Signaling |
171 |
| Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity |
129 |
| Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease |
106 |
| Sedentary Behavior, Exercise, and Cardiovascular Health |
105 |
| Preeclampsia Pathophysiology, Challenges, and Perspectives |
87 |
| NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis |
79 |
| Heart Failure With Preserved Ejection Fraction In Perspective |
76 |
| Immunity and Inflammation in Atherosclerosis |
75 |
| Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis |
73 |
| Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis |
69 |
| Mechanisms of Vascular Aging |
67 |
| Calcium Signaling and Reactive Oxygen Species in Mitochondria |
63 |
| Statin Toxicity Mechanistic Insights and Clinical Implications |
62 |
| The Mediterranean Diet and Cardiovascular Health A Critical Review |
59 |
| New Insights Into the Role of mTOR Signaling in the Cardiovascular System |
54 |
| Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry |
51 |
| Tissue Resident CCR2-and CCR2+Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury |
50 |
| Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies |
50 |
| HDL and Reverse Cholesterol Transport Basic Mechanisms and Their Roles in Vascular Health and Disease |
49 |
| Long Noncoding RNA Discovery in Cardiovascular Disease Decoding Form to Function |
48 |
| Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases |
48 |
| Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy |
46 |
| Cardiovascular Effects of New Oral Glucose-Lowering Agents DPP-4 and SGLT-2 Inhibitors |
45 |
| The Extracellular Matrix in Ischemic and Nonischemic Heart Failure |
44 |
| AMPK2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation |
44 |
| Adherence in Hypertension A Review of Prevalence, Risk Factors, Impact, and Management |
42 |
| Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b |
41 |
| Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease |
41 |
| Reassessing the Mechanisms of Acute Coronary Syndromes The Vulnerable Plaque and Superficial Erosion |
39 |
| Neurovascular and Cognitive Dysfunction in Hypertension Epidemiology, Pathobiology, and Treatment |
39 |
| CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease |
39 |
| MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo |
39 |
| Anticytokine Agents Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis |
37 |
| Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models |
37 |
| Cardiovascular Metabolomics |
36 |
| Management of Myocarditis-Related Cardiomyopathy in Adults |
35 |
| Circ_Lrp a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function |
35 |
| Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health A Review of Emerging Biologic Pathways |
34 |
| Metabolic Coordination of Physiological and Pathological Cardiac Remodeling |
33 |
| Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP DRP and OPA1 That Promote Mitochondrial Fission |
33 |
| Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs |
33 |
| Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression |
33 |
| PCSK9 From Basic Science Discoveries to Clinical Trials |
32 |
| Emerging Role of Precision Medicine in Cardiovascular Disease |
32 |
| Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk |
32 |
| Longterm Exercise-Derived Exosomal miR-342-5p A Novel Exerkine for Cardioprotection |
32 |
| Lipid-Lowering Agents Targets Beyond PCSK9 |
31 |
| A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis |
31 |
| Autophagy in Cardiovascular Aging |
30 |
| Established and Emerging Roles of Biomarkers in Heart Failure |
30 |
